Compositions and methods for improving quality of life in patients with autism spectrum disorder
Grant
US12582148B2
Kind: B2
Mar 24, 2026
Assignee
FLAASK, LLC
Inventors
Andrew R. Lefkowitz, Ken Alibek
Abstract
The present invention provides compositions and methods for treating a subject diagnosed with ASD. In preferred embodiments, the subject compositions comprise tellimagrandin II, glycyrrhizin, monolaurin, selenium, honokiol, a probiotic, and one or more biological amphiphilic molecules, which when administered to a subject, can support immune and/or digestive health, and suppress and/or disable viral pathogenic agents in the body.
CPC Classifications
A23L 33/16
A23L 33/125
A23L 33/135
A61K 31/105
A61K 31/23
A61K 31/704
A61K 31/7048
A61K 33/04
A61K 35/74
Filing Date
2020-01-25
Application No.
17299367
Claims
3